Neuropathy of the Suprascapular Nerve Before and After Reconstruction of the Cuff
Neurospura
1 other identifier
interventional
20
1 country
1
Brief Summary
The suprascapular nerve innervates the musculi supra- and infraspinatus, which, as part of the rotator cuff, allow lifting and external rotation in the shoulder joint. Damage to this nerve can lead to pain and functional deficit. Causes of injury are compression by bony / ligamentous anomalies, fracture sequelae and traction damage. In the literature, a (often subclinical) traction damage is increasingly claimed by a muscle retraction after rupture of the supra- and / or infraspinatus tendon as a cause of pain and functional disturbances. The retraction of the ruptured tendon-muscular unit is said to lead to traction damage of the nerve, which can be demonstrated by pathological EMG derivations. By repositioning the tendon to its outbreak site, the nerve is occasionally overstretched, so that individual authors propagate a routine nerve decompression as prophylaxis. In individual cases, a previously pathologic EMG result could be improved after reconstitution of an rotator cuff rupture. However, prospective studies are not available. It is not known how often a nerve damage is present before a rotator cuff operation and it is not known how often the tendon repair leads to nerve damage or recovery of damage. It is not known whether the surgical nerve decompression is associated with reduced postoperative pain and what a profit or what risks bring about a routine decompression of the nerve to the patient. To answer this question, this prospective randomized study is to be carried out.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2014
CompletedFirst Submitted
Initial submission to the registry
June 29, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 18, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
February 18, 2019
CompletedFirst Posted
Study publicly available on registry
May 16, 2019
CompletedMay 16, 2019
May 1, 2019
5.1 years
June 29, 2017
May 14, 2019
Conditions
Outcome Measures
Primary Outcomes (3)
electromyographic assessment of suprascapular nerve function
sharp waves, complex repetitive discharges and fasciculations in supra- and infraspinatus muscles. Presence or absence
preoperatively, change from preoperatively to 3 months and change from 3 to 12 months
electromyographic assessment of suprascapular nerve function
motor latency to supra- and infraspinatus muscles milliseconds
preoperatively, change from preoperatively to 3 months and change from 3 to 12 months
electromyographic assessment of suprascapular nerve function
conduction velocity (m/sec)
preoperatively, change from preoperatively to 3 months and change from 3 to 12 months
Secondary Outcomes (3)
Maximal daily pain on visual analog scale
preoperatively and change from preoperatively to 3 months and change from 3 to 12 months
Active range of motion
preoperatively and change from preoperatively to 3 months and change from 3 to 12 months
Strength
preoperatively and change from preoperatively to 3 months and change from 3 to 12 months
Study Arms (2)
no release
ACTIVE COMPARATORno release of the suprascapular nerve during arthroscopic repair of a rotator cuff tendon repair
release
EXPERIMENTALarthroscopic release of the suprascapular nerve according to the established, standard technique during arthroscopic repair of a rotator cuff tendon repair
Interventions
Eligibility Criteria
You may qualify if:
- Informed Consent
- MRI diagnosis of partial or full thickness rotator cuff tear
You may not qualify if:
- Previous surgery
- Fatty muscle infiltration Goutallier stages III and IV
- Diabetes mellitus
- pregnancy
- unwillingness or contraindications for Magnetic resonance imaging
- unwillingness or contraindications to electrophysiological assessment
- substance abuse
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Balgrist
Zurich, 8008, Switzerland
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 29, 2017
First Posted
May 16, 2019
Study Start
January 1, 2014
Primary Completion
February 18, 2019
Study Completion
February 18, 2019
Last Updated
May 16, 2019
Record last verified: 2019-05